A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy

Clinical trial NCT07414927 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07414927
Sponsor: Shanghai Best-Link Bioscience, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Carcinoma of Lung

Start date: 2026-03-27
Primary completion: 2027-12-22
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.